Free Trial

Oscar Health (OSCR) Competitors

Oscar Health logo
$33.71 -0.30 (-0.89%)
Closing price 03:59 PM Eastern
Extended Trading
$33.67 -0.03 (-0.09%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

OSCR vs. CNC, MOH, HQY, CLOV, and ALHC

Should you buy Oscar Health stock or one of its competitors? Oscar Health's main competitors and comparable companies include Centene (CNC), Molina Healthcare (MOH), HealthEquity (HQY), Clover Health Investments (CLOV), and Alignment Healthcare (ALHC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "managed healthcare" industry.

How does Oscar Health compare to Centene?

Oscar Health (NYSE:OSCR) and Centene (NYSE:CNC) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership and risk.

Oscar Health has a beta of 2.47, suggesting that its share price is 147% more volatile than the broader market. Comparatively, Centene has a beta of 1.13, suggesting that its share price is 13% more volatile than the broader market.

Oscar Health has higher earnings, but lower revenue than Centene. Centene is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.89-$443.15M$1.4024.08
Centene$194.78B0.17-$6.67B-$10.44N/A

Oscar Health currently has a consensus target price of $34.90, indicating a potential upside of 3.54%. Centene has a consensus target price of $70.05, indicating a potential upside of 1.69%. Given Oscar Health's stronger consensus rating and higher possible upside, analysts clearly believe Oscar Health is more favorable than Centene.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.38
Centene
2 Sell rating(s)
10 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.33

In the previous week, Centene had 18 more articles in the media than Oscar Health. MarketBeat recorded 23 mentions for Centene and 5 mentions for Oscar Health. Centene's average media sentiment score of 0.84 beat Oscar Health's score of 0.57 indicating that Centene is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Centene
11 Very Positive mention(s)
4 Positive mention(s)
6 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 93.6% of Centene shares are owned by institutional investors. 22.6% of Oscar Health shares are owned by insiders. Comparatively, 0.4% of Centene shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Oscar Health has a net margin of 3.60% compared to Centene's net margin of -2.51%. Oscar Health's return on equity of 38.45% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health3.60% 38.45% 6.76%
Centene -2.51%12.12%3.20%

Summary

Oscar Health beats Centene on 12 of the 17 factors compared between the two stocks.

How does Oscar Health compare to Molina Healthcare?

Oscar Health (NYSE:OSCR) and Molina Healthcare (NYSE:MOH) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, dividends, media sentiment and valuation.

Molina Healthcare has higher revenue and earnings than Oscar Health. Molina Healthcare is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oscar Health$11.70B0.89-$443.15M$1.4024.08
Molina Healthcare$45.43B0.24$472M-$0.18N/A

Oscar Health currently has a consensus target price of $34.90, indicating a potential upside of 3.54%. Molina Healthcare has a consensus target price of $202.44, indicating a potential downside of 3.31%. Given Oscar Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Oscar Health is more favorable than Molina Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oscar Health
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.38
Molina Healthcare
2 Sell rating(s)
11 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.18

Oscar Health has a net margin of 3.60% compared to Molina Healthcare's net margin of -0.02%. Oscar Health's return on equity of 38.45% beat Molina Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Oscar Health3.60% 38.45% 6.76%
Molina Healthcare -0.02%3.73%0.97%

In the previous week, Molina Healthcare had 1 more articles in the media than Oscar Health. MarketBeat recorded 6 mentions for Molina Healthcare and 5 mentions for Oscar Health. Molina Healthcare's average media sentiment score of 0.86 beat Oscar Health's score of 0.57 indicating that Molina Healthcare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oscar Health
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Molina Healthcare
4 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Oscar Health has a beta of 2.47, indicating that its stock price is 147% more volatile than the broader market. Comparatively, Molina Healthcare has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

75.7% of Oscar Health shares are owned by institutional investors. Comparatively, 98.5% of Molina Healthcare shares are owned by institutional investors. 22.6% of Oscar Health shares are owned by company insiders. Comparatively, 1.4% of Molina Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Oscar Health beats Molina Healthcare on 10 of the 16 factors compared between the two stocks.

How does Oscar Health compare to HealthEquity?

HealthEquity (NASDAQ:HQY) and Oscar Health (NYSE:OSCR) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, risk, analyst recommendations, earnings, valuation, profitability and institutional ownership.

HealthEquity has a net margin of 17.36% compared to Oscar Health's net margin of 3.60%. Oscar Health's return on equity of 38.45% beat HealthEquity's return on equity.

Company Net Margins Return on Equity Return on Assets
HealthEquity17.36% 15.33% 9.51%
Oscar Health 3.60%38.45%6.76%

HealthEquity has a beta of 0.24, meaning that its stock price is 76% less volatile than the broader market. Comparatively, Oscar Health has a beta of 2.47, meaning that its stock price is 147% more volatile than the broader market.

HealthEquity has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HealthEquity$1.31B5.68$215.20M$2.7732.56
Oscar Health$11.70B0.89-$443.15M$1.4024.08

In the previous week, HealthEquity and HealthEquity both had 5 articles in the media. Oscar Health's average media sentiment score of 0.57 beat HealthEquity's score of 0.55 indicating that Oscar Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
HealthEquity
1 Very Positive mention(s)
2 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Oscar Health
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.6% of HealthEquity shares are held by institutional investors. Comparatively, 75.7% of Oscar Health shares are held by institutional investors. 1.6% of HealthEquity shares are held by insiders. Comparatively, 22.6% of Oscar Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

HealthEquity presently has a consensus target price of $112.20, indicating a potential upside of 24.40%. Oscar Health has a consensus target price of $34.90, indicating a potential upside of 3.54%. Given HealthEquity's stronger consensus rating and higher possible upside, analysts plainly believe HealthEquity is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HealthEquity
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
1 Strong Buy rating(s)
2.85
Oscar Health
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.38

Summary

HealthEquity beats Oscar Health on 10 of the 15 factors compared between the two stocks.

How does Oscar Health compare to Clover Health Investments?

Clover Health Investments (NASDAQ:CLOV) and Oscar Health (NYSE:OSCR) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, analyst recommendations, institutional ownership and media sentiment.

Clover Health Investments currently has a consensus price target of $4.75, indicating a potential downside of 1.25%. Oscar Health has a consensus price target of $34.90, indicating a potential upside of 3.54%. Given Oscar Health's stronger consensus rating and higher probable upside, analysts clearly believe Oscar Health is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.17
Oscar Health
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.38

Clover Health Investments has higher earnings, but lower revenue than Oscar Health. Clover Health Investments is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Clover Health Investments$1.92B1.33-$85.55M-$0.05N/A
Oscar Health$11.70B0.89-$443.15M$1.4024.08

Oscar Health has a net margin of 3.60% compared to Clover Health Investments' net margin of -0.74%. Oscar Health's return on equity of 38.45% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Clover Health Investments-0.74% -4.20% -2.28%
Oscar Health 3.60%38.45%6.76%

19.8% of Clover Health Investments shares are owned by institutional investors. Comparatively, 75.7% of Oscar Health shares are owned by institutional investors. 23.5% of Clover Health Investments shares are owned by company insiders. Comparatively, 22.6% of Oscar Health shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Clover Health Investments has a beta of 2.45, meaning that its stock price is 145% more volatile than the broader market. Comparatively, Oscar Health has a beta of 2.47, meaning that its stock price is 147% more volatile than the broader market.

In the previous week, Clover Health Investments had 6 more articles in the media than Oscar Health. MarketBeat recorded 11 mentions for Clover Health Investments and 5 mentions for Oscar Health. Oscar Health's average media sentiment score of 0.57 beat Clover Health Investments' score of 0.56 indicating that Oscar Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Clover Health Investments
3 Very Positive mention(s)
2 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Oscar Health
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Oscar Health beats Clover Health Investments on 13 of the 17 factors compared between the two stocks.

How does Oscar Health compare to Alignment Healthcare?

Alignment Healthcare (NASDAQ:ALHC) and Oscar Health (NYSE:OSCR) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, media sentiment, risk, valuation and institutional ownership.

Oscar Health has a net margin of 3.60% compared to Alignment Healthcare's net margin of 0.89%. Oscar Health's return on equity of 38.45% beat Alignment Healthcare's return on equity.

Company Net Margins Return on Equity Return on Assets
Alignment Healthcare0.89% 20.02% 3.46%
Oscar Health 3.60%38.45%6.76%

Alignment Healthcare currently has a consensus target price of $16.82, indicating a potential upside of 102.63%. Oscar Health has a consensus target price of $34.90, indicating a potential upside of 3.54%. Given Alignment Healthcare's stronger consensus rating and higher probable upside, equities analysts clearly believe Alignment Healthcare is more favorable than Oscar Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Alignment Healthcare
0 Sell rating(s)
5 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.58
Oscar Health
1 Sell rating(s)
7 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.38

86.2% of Alignment Healthcare shares are owned by institutional investors. Comparatively, 75.7% of Oscar Health shares are owned by institutional investors. 5.2% of Alignment Healthcare shares are owned by insiders. Comparatively, 22.6% of Oscar Health shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, Alignment Healthcare had 29 more articles in the media than Oscar Health. MarketBeat recorded 34 mentions for Alignment Healthcare and 5 mentions for Oscar Health. Oscar Health's average media sentiment score of 0.57 beat Alignment Healthcare's score of 0.03 indicating that Oscar Health is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Alignment Healthcare
4 Very Positive mention(s)
6 Positive mention(s)
10 Neutral mention(s)
9 Negative mention(s)
0 Very Negative mention(s)
Neutral
Oscar Health
2 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Alignment Healthcare has higher earnings, but lower revenue than Oscar Health. Oscar Health is trading at a lower price-to-earnings ratio than Alignment Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alignment Healthcare$3.95B0.44-$720K$0.1943.68
Oscar Health$11.70B0.89-$443.15M$1.4024.08

Alignment Healthcare has a beta of 1.14, indicating that its stock price is 14% more volatile than the broader market. Comparatively, Oscar Health has a beta of 2.47, indicating that its stock price is 147% more volatile than the broader market.

Summary

Oscar Health beats Alignment Healthcare on 10 of the 17 factors compared between the two stocks.

Get Oscar Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for OSCR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding OSCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

OSCR vs. The Competition

MetricOscar HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$10.50B$10.01B$7.27B$23.13B
Dividend YieldN/A2.61%2.52%3.72%
P/E Ratio24.0828.34193.1121.01
Price / Sales0.894.79561.7722.63
Price / CashN/A116.3177.1637.05
Price / Book10.255.1410.714.73
Net Income-$443.15M$315.68M$3.50B$1.07B
7 Day Performance4.45%-1.03%-3.18%-0.48%
1 Month Performance3.08%-2.93%-6.61%-3.50%
1 Year Performance65.52%11.33%3.69%7.66%

Oscar Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OSCR
Oscar Health
4.4032 of 5 stars
$33.71
-0.9%
$34.90
+3.5%
+80.4%$10.50B$11.70B24.082,305
CNC
Centene
4.2596 of 5 stars
$64.25
+2.0%
$70.05
+9.0%
+87.6%$31.74B$194.78BN/A61,100
MOH
Molina Healthcare
2.4747 of 5 stars
$194.42
+2.6%
$202.44
+4.1%
+5.5%$10.15B$45.43BN/A19,000
HQY
HealthEquity
4.4382 of 5 stars
$91.55
+1.7%
$112.20
+22.6%
+1.7%$7.57B$1.31B33.052,814
CLOV
Clover Health Investments
2.2109 of 5 stars
$4.68
+6.8%
$4.75
+1.5%
+86.7%$2.49B$1.92BN/A724

Related Companies and Tools


This page (NYSE:OSCR) was last updated on 10/13/2026 by MarketBeat.com Staff.
From Our Partners